Cardiff Oncology, Inc. earnings per share and revenue

CRDF earnings per share for the last quarter are -0.25 USD whereas the estimation was -0.27 USD which accounts for 7.22% surprise. Company revenue for the same period amounts to 165.00 k USD despite the estimated figure of 70.00 k USD. Estimated earnings per share for the next quarter are -0.25 USD, and revenue is expected to reach 80.00 k USD. Also watch annual changes over time to get a bigger picture of CRDF earnings per share and revenue dynamics.